Skip to main content
. 2015 Sep 25;4(3):168–176. doi: 10.1055/s-0035-1564570

Fig. 2.

Fig. 2

Distribution of scores for Rett syndrome patients (no. 13), Angelman syndrome patients (no. 16), Mowat–Wilson syndrome patients (no. 14), patients with a negative TCF4 molecular test (no. 60), and PTHS patients with a proven TCF4 alteration (no. 18), using the proposed clinical scoring system (already presented in “Marangi et al16).